Cas no 54490-26-5 (Naphtho[2,3-f]quinoxaline-7,12-dione)
Naphtho[2,3-f]quinoxaline-7,12-dione Chemical and Physical Properties
Names and Identifiers
-
- Naphtho[2,3-f]quinoxaline-7,12-dione
- NSC745887
- Naphtho(3,2-f)quinoxaline-7,12-dione
- NSC 745887
- JW9DZV2DT3
- 54490-26-5
- UNII-JW9DZV2DT3
- naphtho[3,2-f]quinoxaline-7,12-dione
- 7,12-Dihydro-7,12-dioxoanthra(1,2-b)pyrazine
- SCHEMBL2396625
- HY-123786
- CHEMBL596064
- CS-0085767
- NSC-745887
- DGLSEJAACVWJNU-UHFFFAOYSA-N
- DA-66233
-
- Inchi: 1S/C16H8N2O2/c19-15-9-3-1-2-4-10(9)16(20)13-11(15)5-6-12-14(13)18-8-7-17-12/h1-8H
- InChI Key: DGLSEJAACVWJNU-UHFFFAOYSA-N
- SMILES: O=C1C2C=CC=CC=2C(C2C=CC3C(C=21)=NC=CN=3)=O
Computed Properties
- Exact Mass: 260.05864
- Monoisotopic Mass: 260.058577502g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 20
- Rotatable Bond Count: 0
- Complexity: 436
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.2
- Topological Polar Surface Area: 59.9?2
Experimental Properties
- PSA: 59.92
Naphtho[2,3-f]quinoxaline-7,12-dione Security Information
- Signal Word:Warning
- Storage Condition:Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Naphtho[2,3-f]quinoxaline-7,12-dione Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| S e l l e c k ZHONG GUO | S0527-5mg |
NSC745887 |
54490-26-5 | 5mg |
¥3333.33 | 2022-04-26 | ||
| S e l l e c k ZHONG GUO | S0527-25mg |
NSC745887 |
54490-26-5 | 25mg |
¥10065.51 | 2022-04-26 | ||
| Axon Medchem | 2966-10 mg |
NSC745887 |
54490-26-5 | 99% | 10mg |
€95.00 | 2023-07-10 | |
| Axon Medchem | 2966-50 mg |
NSC745887 |
54490-26-5 | 99% | 50mg |
€295.00 | 2023-07-10 | |
| Axon Medchem | 2966-10mg |
NSC745887 |
54490-26-5 | 99% | 10mg |
€95.00 | 2025-03-06 | |
| Axon Medchem | 2966-50mg |
NSC745887 |
54490-26-5 | 99% | 50mg |
€295.00 | 2025-03-06 | |
| Biosynth | ECA49026-5 mg |
NSC745887 |
54490-26-5 | 5mg |
$258.50 | 2023-01-05 | ||
| Biosynth | ECA49026-10 mg |
NSC745887 |
54490-26-5 | 10mg |
$413.60 | 2023-01-05 | ||
| Biosynth | ECA49026-25 mg |
NSC745887 |
54490-26-5 | 25mg |
$775.50 | 2023-01-05 | ||
| Biosynth | ECA49026-50 mg |
NSC745887 |
54490-26-5 | 50mg |
$1,241.00 | 2023-01-05 |
Naphtho[2,3-f]quinoxaline-7,12-dione Related Literature
-
Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
Additional information on Naphtho[2,3-f]quinoxaline-7,12-dione
Naphtho[2,3-f]quinoxaline-7,12-dione: A Comprehensive Overview
Naphtho[2,3-f]quinoxaline-7,12-dione, also known by its CAS registry number CAS No. 54490-26-5, is a highly aromatic heterocyclic compound that has garnered significant attention in the fields of organic chemistry and materials science. This compound is characterized by its unique molecular structure, which consists of a naphthoquinoline framework fused with a quinoxaline moiety. The presence of two ketone groups at positions 7 and 12 imparts distinctive electronic and optical properties to the molecule.
Recent studies have highlighted the potential of Naphtho[2,3-f]quinoxaline-7,12-dione as a building block for advanced functional materials. Researchers have explored its application in the development of organic semiconductors, where its high electron-deficient character and planar conjugated system make it an ideal candidate for use in field-effect transistors (FETs) and organic photovoltaics (OPVs). The compound's ability to form stable charge transfer complexes with electron-rich donors has further expanded its utility in optoelectronic devices.
In terms of synthesis, Naphtho[2,3-f]quinoxaline-7,12-dione can be prepared through various routes, including oxidative coupling reactions and cyclization processes. One notable method involves the condensation of o-phenylenediamine derivatives with suitable carbonyl compounds under controlled oxidative conditions. This approach not only ensures high yield but also allows for structural modifications to tailor the compound's properties for specific applications.
The electronic properties of Naphtho[2,3-f]quinoxaline-7,12-dione have been extensively studied using computational chemistry techniques such as density functional theory (DFT). These studies reveal that the molecule exhibits a relatively low lying LUMO (Lowest Unoccupied Molecular Orbital), which is advantageous for electron acceptor applications. Additionally, its high molar absorptivity in the visible region suggests potential uses in light-harvesting materials.
From a biological standpoint, preliminary assays indicate that Naphtho[2,3-f]quinoxaline-7,12-dione may exhibit moderate cytotoxicity against certain cancer cell lines. This observation has prompted further investigations into its potential as an anticancer agent or as a scaffold for drug discovery. However, more comprehensive studies are required to fully understand its pharmacokinetic profile and mechanism of action.
In conclusion, Naphtho[2,3-f]quinoxaline-7,12-dione represents a versatile compound with promising applications across multiple disciplines. Its unique structure and electronic properties make it a valuable tool for researchers in the development of next-generation materials and therapeutic agents. As ongoing research continues to uncover new insights into its behavior and functionality, this compound is poised to play an increasingly important role in both academic and industrial settings.
54490-26-5 (Naphtho[2,3-f]quinoxaline-7,12-dione) Related Products
- 89986-91-4(Naphtho[2,3-f]quinoxaline-7,12-dione, 2,3-dimethyl-)
- 1056877-23-6(1-(1,5-naphthyridin-4-yl)-Ethanone)
- 82789-83-1(23,30-dihydro-5H-tetranaphtho[2,3-a:2',3'-a':2'',3''-i:2''',3'''-i']pyrrolo[2,3-c:5,4-c']dicarbazole-5,7,12,17,22,24,29,31(6H)-octone)
- 89334-33-8(5-Quinoxalinecarboxaldehyde, 8-acetyl-)
- 2172-33-0(C.I.Vat Orange 11)
- 62386-24-7(Ethanone, 1,1'-(1,7-phenazinediyl)bis-)
- 46492-08-4(Benz[g]isoquinoline-5,10-dione)
- 2475-33-4(Vat Brown 1)
- 89334-34-9(Ethanone,1-(5-quinoxalinyl)-)
- 4229-15-6(5H-Dinaphtho[2,3-a:2',3'-i]carbazole-5,10,15,17(16H)-tetrone)